Royal Bank of Canada’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $176K | Buy |
41,983
+1,983
| +5% | +$8.31K | ﹤0.01% | 4911 |
|
2025
Q1 | $191K | Sell |
40,000
-2,303
| -5% | -$11K | ﹤0.01% | 4388 |
|
2024
Q4 | $161K | Buy |
42,303
+9,079
| +27% | +$34.6K | ﹤0.01% | 4540 |
|
2024
Q3 | $298K | Buy |
+33,224
| New | +$298K | ﹤0.01% | 4086 |
|
2024
Q2 | – | Sell |
-9
| Closed | – | – | 6718 |
|
2024
Q1 | $0 | Buy |
9
+4
| +80% | – | ﹤0.01% | 6622 |
|
2023
Q4 | $0 | Sell |
5
-6
| -55% | – | ﹤0.01% | 6650 |
|
2023
Q3 | $0 | Sell |
11
-84
| -88% | – | ﹤0.01% | 6648 |
|
2023
Q2 | $2K | Buy |
95
+36
| +61% | +$758 | ﹤0.01% | 6398 |
|
2023
Q1 | $2K | Buy |
59
+52
| +743% | +$1.76K | ﹤0.01% | 6371 |
|
2022
Q4 | $0 | Sell |
7
-41
| -85% | – | ﹤0.01% | 6823 |
|
2022
Q3 | $2K | Buy |
48
+43
| +860% | +$1.79K | ﹤0.01% | 6512 |
|
2022
Q2 | $0 | Sell |
5
-1,675
| -100% | – | ﹤0.01% | 6940 |
|
2022
Q1 | $155K | Sell |
1,680
-827
| -33% | -$76.3K | ﹤0.01% | 4836 |
|
2021
Q4 | $557K | Buy |
2,507
+384
| +18% | +$85.3K | ﹤0.01% | 3861 |
|
2021
Q3 | $735K | Sell |
2,123
-204
| -9% | -$70.6K | ﹤0.01% | 3535 |
|
2021
Q2 | $874K | Sell |
2,327
-136
| -6% | -$51.1K | ﹤0.01% | 3372 |
|
2021
Q1 | $765K | Buy |
2,463
+18
| +0.7% | +$5.59K | ﹤0.01% | 3395 |
|
2020
Q4 | $612K | Buy |
2,445
+844
| +53% | +$211K | ﹤0.01% | 3477 |
|
2020
Q3 | $296K | Buy |
1,601
+595
| +59% | +$110K | ﹤0.01% | 3798 |
|
2020
Q2 | $251K | Sell |
1,006
-474
| -32% | -$118K | ﹤0.01% | 3846 |
|
2020
Q1 | $268K | Buy |
1,480
+56
| +4% | +$10.1K | ﹤0.01% | 3659 |
|
2019
Q4 | $593K | Buy |
1,424
+1,327
| +1,368% | +$553K | ﹤0.01% | 3311 |
|
2019
Q3 | $24K | Hold |
97
| – | – | ﹤0.01% | 4814 |
|
2019
Q2 | $38K | Buy |
+97
| New | +$38K | ﹤0.01% | 4711 |
|